CSL Limited CSL.AX
AU · Australian Securities Exchange · XASX · stock · Healthcare · website
CSL Limited statistics & valuation
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
CSL Limited trades at about 18.6× earnings — below its 10-year norm (10-year range 43.9×–60.4×, median 59.3×).
18.6×
60.4×
Shaded band = 10-year range (43.9×–60.4×); dot = today's 18.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 51.5% | 51.5% | 50.9% | 54.0% |
| Operating margin | 19.2% | 18.8% | 16.0% | 22.1% |
| Net margin | 19.5% | 18.0% | 16.7% | 21.5% |
| Return on assets | 7.6% | 6.9% | 6.1% | 8.0% |
| Return on equity | 15.5% | 15.2% | 13.9% | 15.5% |
| Debt / equity | 0.47× | 0.56× | 0.61× | 0.26× |
| Current ratio | 2.46 | 2.18 | 2.01 | 2.32 |
Source: company filings via Yahoo Finance · AU · as of 2025-06-30. Figures in AUD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.